soluble scf mast cell celldex - SERP Analysis

https://celldex.com/wp-content/uploads/CLDX-AAI-May-2023.pdf

https://ir.celldex.com/news-releases/news-release-details/celldex-therapeutics-presents-positive-preclinical-data

https://ir.celldex.com/node/15906/pdf

https://pmc.ncbi.nlm.nih.gov/articles/PMC9544977/

https://journals.aai.org/jimmunol/article/210/1_Supplement/246.07/264906/Dual-targeting-of-mast-cells-and-TSLP-with-a

https://pmc.ncbi.nlm.nih.gov/articles/PMC3358494/

https://www.stocktitan.net/news/CLDX/celldex-therapeutics-presents-positive-preclinical-data-from-bftdr0oxrxta.html

https://www.nature.com/articles/s41467-022-30103-2

https://ashpublications.org/blood/article/96/4/1267/258441/Soluble-stem-cell-factor-receptor-CD117-and-IL-2

https://www.pnas.org/doi/10.1073/pnas.94.17.9017

https://journals.aai.org/jimmunol/article/188/11/5428/86802/Stem-Cell-Factor-Programs-the-Mast-Cell-Activation

https://www.sciencedirect.com/science/article/pii/S0022202X15339427

https://www.stemcell.com/products/human-recombinant-scf.html

https://www.jacionline.org/article/S0091-6749(96)70133-1/fulltext

https://www.sciencedirect.com/science/article/pii/S0006497120537245

https://en.wikipedia.org/wiki/Stem_cell_factor

https://www.nature.com/articles/s41419-023-06139-7

https://karger.com/aha/article/105/3/143/13987/Stem-Cell-Factor-Biology-and-Relevance-to-Clinical

https://ashpublications.org/blood/article/90/4/1345/238115/Stem-Cell-Factor-and-Hematopoiesis

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.794974/full

https://onlinelibrary.wiley.com/doi/10.1046/j.1365-3083.1999.00519.x

https://www.biolegend.com/nl-nl/products/purified-anti-scf-antibody-10453

https://www.prospecbio.com/scf

https://haematologica.org/article/view/9698

https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-017-0504-2

https://www.laboratoryinvestigation.org/article/S0023-6837(22)03623-6/fulltext

https://academic.oup.com/ibdjournal/article-pdf/29/7/1133/50693901/izad003.pdf

https://www.miltenyibiotec.com/US-en/products/human-scf.html

https://synapse.patsnap.com/article/celldex-reveals-promising-preclinical-data-for-cdx-622-at-aaaai-2025

https://www.jacionline.org/article/S0091-6749(22)00550-4/pdf

https://deepblue.lib.umich.edu/bitstream/2027.42/74417/1/j.1600-0722.2006.00388.x.pdf

https://www.jaad.org/article/S0022-202X(15)40548-2/fulltext

https://journals.physiology.org/doi/prev/20191120-aop/pdf/10.1152/ajplung.00114.2019

https://www.bioworld.com/articles/717555-celldexs-cdx-622-shows-promise-for-inflammatory-disorders

https://www.usbio.net/antibodies/145142/SCF/data-sheet

https://www.rndsystems.com/products/simple-plex-control-for-human-scf-c-kit-ligand_898316

https://www.clinicaltrialvanguard.com/news/celldexs-cdx-622-shows-promise-in-preclinical-inflammatory-disease-study/

https://atlasgeneticsoncology.org/gene/142/kitlg-(kit-ligand)

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.97.10.971

https://www.cell.com/fulltext/S0092-8674(17)30189-7

https://www.caymanchem.com/product/32051/scf-extracellular-domain-(human%2C-recombinant)?srsltid=AfmBOorps8jrkaUHmf_lIfmeFvHLqNeCRSKsef9LUhg8Rf5GB_nY3u7C

https://link.springer.com/article/10.1007/s12016-017-8619-2

https://patents.google.com/patent/WO2024186635A2/en

https://www.researchgate.net/figure/KIT-activation-in-normal-mast-cells-Under-normal-conditions-soluble-SCF-binds-to-KIT_fig1_340624118

https://www.biolegend.com/ja-jp/products/recombinant-human-scf-carrier-free-7591?GroupID=GROUP577

https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/204/006/s2437dat.pdf?srsltid=AfmBOoovh0iQHWg2J34Q3p46pRvzlNQ-h6QBKaJr4pKrDKI4gKbCUVxA

https://journals.physiology.org/doi/full/10.1152/ajplung.00114.2019

https://linkinghub.elsevier.com/retrieve/pii/S1046592814002125

https://www.opsidio.com/blank-page-1

https://scite.ai/reports/chymase-cleavage-of-stem-cell-dRgmed

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049615

http://www.neuro-lab.com/products/52/index.html

https://bmcpulmmed.biomedcentral.com/articles/10.1186/1471-2466-9-27

https://www.rndsystems.com/products/recombinant-rat-scf-protein_6998-sc

https://academic.oup.com/jimmunol/article/210/Supplement_1/246.07/7947734

https://www.prospecbio.com/scf_human

https://www.theglobeandmail.com/investing/markets/stocks/CLDX/pressreleases/31206359/celldex-therapeutics-presents-positive-preclinical-data-from-inflammatory-bispecific-antibody-program-cdx-622-at-aaaai-2025/

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.604192/full

https://ir.celldex.com/news-releases/news-release-details/celldex-therapeutics-presents-positive-data-barzolvolimab-phase

https://research.uni-luebeck.de/en/publications/anti-kit-antibody-barzolvolimab-reduces-skin-mast-cells-and-disea

https://www.thermofisher.com/proteins/product/Human-SCF-Recombinant-Protein/RSCF10

https://www.miltenyibiotec.com/US-en/products/mouse-scf.html

https://www.researchgate.net/figure/SCF-isoforms-and-a-SCF248-Endogenous-SCF-is-found-in-2-primary-forms-SCF220-and-SCF248_fig1_330224620

https://scispace.com/pdf/anti-kit-antibody-barzolvolimab-reduces-skin-mast-cells-and-w79nctsdlz.pdf

https://cdn.stemcell.com/media/files/pis/DX20577-PIS_1_0_0.pdf

https://www.stocktitan.net/news/CLDX/

https://synapse.patsnap.com/target/fb6512bfa64c460ea051cc787cf8de4e

https://pub.epsilon.slu.se/id/document/20389076

https://patents.google.com/patent/US7915391B2/en

https://ir.celldex.com/news-releases/news-release-details/celldex-therapeutics-presents-positive-data-cdx-0159-phase-1b

https://finance.yahoo.com/news/celldex-therapeutics-presents-positive-preclinical-130100809.html

http://www.jaspertx.com/wp-content/uploads/2024/06/EMBRN-poster-2024.pdf

https://www.globenewswire.com/de/news-release/2025/03/03/3035595/24180/en/Celldex-Therapeutics-Presents-Positive-Preclinical-Data-from-Inflammatory-Bispecific-Antibody-Program-CDX-622-at-AAAAI-2025.html

https://www.nasdaq.com/press-release/celldex-therapeutics-presents-positive-preclinical-data-inflammatory-bispecific

https://whnt.com/business/press-releases/globenewswire/9387560/celldex-therapeutics-presents-positive-preclinical-data-from-inflammatory-bispecific-antibody-program-cdx-622-at-aaaai-2025/

https://www.thermofisher.com/antibody/product/Phospho-c-Kit-Tyr703-Antibody-clone-53H8L29-Recombinant-Monoclonal/700135

https://br.advfn.com/bolsa-de-valores/nasdaq/CLDX/share-news/95549696/celldex-therapeutics-presents-positive-preclinical-data-from-inflammatory-bispec

https://ir.celldex.com/news-releases/news-release-details/celldex-announces-barzolvolimab-met-all-primary-and-secondary

https://www.pathology.med.umich.edu/lukacs-laboratory/mast-cell-biology-scf

https://www.globenewswire.com/news-release/2022/12/06/2568047/0/en/Celldex-Therapeutics-Presents-Positive-Data-from-Barzolvolimab-Phase-1b-Study-in-Chronic-Inducible-Urticaria-at-Global-Urticaria-Forum-2022.html

https://patents.justia.com/patent/11098107

https://ir.celldex.com/news-releases/news-release-details/celldex-therapeutics-presents-positive-preclinical-data-tslpscf

https://ir.celldex.com/news-releases/news-release-details/celldex-announces-first-patient-dosed-phase-1-healthy-volunteer

https://ir.celldex.com/node/14961/pdf